Ladenburg Thalmann Financial Services’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $80K | Buy |
1,348
+546
| +68% | +$32.4K | ﹤0.01% | 3178 |
|
|
2019
Q3 | $30K | Sell |
802
-25
| -3% | -$935 | ﹤0.01% | 3773 |
|
|
2019
Q2 | $38K | Hold |
827
| – | – | ﹤0.01% | 3635 |
|
|
2019
Q1 | $33K | Sell |
827
-220
| -21% | -$8.78K | ﹤0.01% | 3682 |
|
|
2018
Q4 | $48K | Buy |
1,047
+814
| +349% | +$37.3K | ﹤0.01% | 3272 |
|
|
2018
Q3 | $11K | Sell |
233
-782
| -77% | -$36.9K | ﹤0.01% | 4226 |
|
|
2018
Q2 | $74K | Hold |
1,015
| – | – | ﹤0.01% | 2975 |
|
|
2018
Q1 | $74K | Sell |
1,015
-509
| -33% | -$37.1K | ﹤0.01% | 2975 |
|
|
2017
Q4 | $101K | Sell |
1,524
-40
| -3% | -$2.65K | ﹤0.01% | 2711 |
|
|
2017
Q3 | $79K | Buy |
1,564
+514
| +49% | +$26K | ﹤0.01% | 2753 |
|
|
2017
Q2 | $49K | Buy |
1,050
+164
| +19% | +$7.65K | ﹤0.01% | 3034 |
|
|
2017
Q1 | $31K | Sell |
886
-14
| -2% | -$490 | ﹤0.01% | 3246 |
|
|
2016
Q4 | $11K | Hold |
900
| – | – | ﹤0.01% | 3812 |
|
|
2016
Q3 | $12K | Hold |
900
| – | – | ﹤0.01% | 3706 |
|
|
2016
Q2 | $9K | Hold |
900
| – | – | ﹤0.01% | 3830 |
|
|
2016
Q1 | $15K | Hold |
900
| – | – | ﹤0.01% | 3442 |
|
|
2015
Q4 | $20K | Buy |
+900
| New | +$20K | ﹤0.01% | 3219 |
|